TD Asset Management’s Burning Rock Biotech BNR Stock Holding History

TD Asset Management’s Portfolio BNR Stock Details BNR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-3,359	Closed	-$75.6K	–	1433
2022 Q4	$75.6K	Hold	3,359	–	–	﹤0.01%	1415
2022 Q3	$81K	Hold	3,359	–	–	﹤0.01%	1433
2022 Q2	$98K	Hold	3,359	–	–	﹤0.01%	1413
2022 Q1	$312K	Sell	3,359 -1,350	-29%	-$117K	﹤0.01%	1390
2021 Q4	$449K	Hold	4,709	–	–	﹤0.01%	1396
2021 Q3	$842K	Hold	4,709	–	–	﹤0.01%	1296
2021 Q2	$1.07M	Hold	4,709	–	–	﹤0.01%	1242
2021 Q1	$1.27M	Buy	4,709 +500	+12%	+$152K	﹤0.01%	1218
2020 Q4	$972K	Hold	4,209	–	–	﹤0.01%	1194
2020 Q3	$1.06M	Hold	4,209	–	–	﹤0.01%	1077
2020 Q2	$1.14M	Buy	+4,209	New	+$1.15M	﹤0.01%	1027

Other funds holding BNR

KCM

Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

TD Asset Management's BNR Position: Q1 2023 in Review

TD Asset Management sold out of Burning Rock Biotech (BNR) in Q1 2023, closing a stake of 3,359 shares — an estimated $75.6K sold.

TD Asset Management first reported a position in BNR in Q2 2020 and held it in 11 quarters. The position peaked at $1.27M in Q1 2021. 34 funds tracked by Wall St. Rank hold BNR as of Q1 2023.

TD Asset Management reported no remaining Burning Rock Biotech position as of Q1 2023 after selling out during the quarter.
TD Asset Management sold 3,359 Burning Rock Biotech shares in Q1 2023, an estimated $75.6K.
TD Asset Management first reported a position in Burning Rock Biotech in Q2 2020 and held it in 11 quarters.
TD Asset Management's Burning Rock Biotech position peaked at $1.27M in Q1 2021.
34 funds tracked by Wall St. Rank held Burning Rock Biotech as of Q1 2023.

Based on TD Asset Management's 13F filing for Q1 2023, filed 10 May 2023.